As a Free StocksGuide user, you can view scores for all 7,008 stocks worldwide.
12 Analysts have issued a Conmed Corp. forecast:
12 Analysts have issued a Conmed Corp. forecast:
Jun '25 |
+/-
%
|
||
Revenue | 1,326 1,326 |
4%
4%
|
|
Gross Profit | 743 743 |
5%
5%
|
|
EBITDA | 226 226 |
10%
10%
|
EBIT (Operating Income) EBIT | 191 191 |
12%
12%
|
Net Profit | 110 110 |
12%
12%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
CONMED Corp. operates as a medical technology company, which engages in the development, manufacture and sale of surgical devices and related equipment. It operates through the following geographical segments: United States; Americas excluding the United States; Europe, Middle East, and Africa; and Asia Pacific. Its products are used by surgeons and physicians in a variety of medical specialties, including orthopedic surgery, general surgery, gynecology, neurosurgery, thoracic surgery and gastroenterology. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.
Head office | United States |
CEO | Patrick Beyer |
Employees | 3,900 |
Founded | 1970 |
Website | www.conmed.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.